Supreme Court Set for Battle Over Abortion Drug Access

Danco Laboratories is challenging a recent court ruling that halts the mailing of the abortion drug mifepristone. The pharmaceutical company has appealed to the U.S. Supreme Court, arguing that the ruling disrupts access to a critical reproductive health option, especially in states with abortion bans.

In other health news, a suspected hantavirus outbreak aboard a Netherlands-based cruise ship has resulted in three deaths. The virus, known to cause severe respiratory illness, has raised alarms as the ship remains off Cape Verde, Africa.

Meanwhile, an ongoing strike at Samsung Biologics has led to an estimated financial loss of over $100 million, reflecting disruptions in production lines. Additionally, shares of a2 Milk have plummeted nearly 19% following a U.S. recall due to contamination concerns.

(With inputs from agencies.)